PSC
JNJ icon

Portman Square Capital’s Johnson & Johnson JNJ Stock Holding History

Portman Square Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,265
Closed -$506K – 429
2023
Q1 		$506K Hold
3,265
– – 0.02% 256
2022
Q4 		$577K Buy
+3,265
New +$564K 0.04% 247

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Portman Square Capital's JNJ Position: Q2 2023 in Review

Portman Square Capital sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 3,265 shares — an estimated $506K sold.

Portman Square Capital first reported a position in JNJ in Q4 2022 and held it in 2 quarters. The position peaked at $577K in Q4 2022. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Portman Square Capital reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Portman Square Capital sold 3,265 Johnson & Johnson shares in Q2 2023, an estimated $506K.
  • Portman Square Capital first reported a position in Johnson & Johnson in Q4 2022 and held it in 2 quarters.
  • Portman Square Capital's Johnson & Johnson position peaked at $577K in Q4 2022.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Portman Square Capital's 13F filing for Q2 2023, filed 26 Jul 2023.